SCHEMBL1065004

SCHEMBL1065004

O=C(O)c1ccc(C(=O)N2Cc3ccccc3C2)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.63
HSP90B1 P14625 3/20 0.58
TRAP1 Q12931 2/20 0.58
HPGD P15428 3/20 0.55
LMNA P02545 1/20 0.55
HSP90AA1 P07900 6/20 0.53
HSP90AB1 P08238 6/20 0.53
NOTUM Q6P988 1/20 0.52
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
CA14 Q9ULX7 1/20 0.51
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
AKR1C3 P42330 1/20 0.49
GRM5 P41594 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167985 0.90 NAMPT (0.64) NAMPTHSP90B1TRAP1HPGDLMNA
SCHEMBL1304055 0.85 HSP90B1 (0.63) NAMPTHSP90B1TRAP1HPGDLMNA
SCHEMBL31047689 0.83 PKM (0.62) NAMPTHSP90B1TRAP1HPGDLMNA
SCHEMBL4155125 0.80 NAMPT (0.59) NAMPTHSP90B1TRAP1HPGDLMNA
SCHEMBL29367465 0.80 NAMPT (0.62) NAMPTHSP90B1TRAP1HPGDHSP90AA1
SCHEMBL27147206 0.79 TRAP1 (0.83) HSP90B1TRAP1HSP90AA1HSP90AB1
SCHEMBL17618301 0.78 TRAP1 (0.65) NAMPTHSP90B1TRAP1HPGDLMNA
SCHEMBL4279383 0.78 HPGD (0.73) NAMPTHPGDLMNANOTUMCA1
SCHEMBL30277860 0.78 HPGD (0.73) NAMPTHPGDLMNANOTUMCA1
SCHEMBL3703713 0.78 NAMPT (0.77) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868204-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-7838520-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2010-11-23 US disclosed
US-7595343-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2009-09-29 US disclosed
US-20060058298-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2006-03-16 US disclosed
US-20050288282-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2005-12-29 US disclosed
US-6897220-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2005-05-24 US disclosed
US-20040142953-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2004-07-22 US disclosed
EP-1429765-A2 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2004-06-23 EP disclosed
US-20040106599-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2004-06-03 US disclosed
WO-2003024448-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288282-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 NAMPT 243/4885HSP90B1 1260/4885TRAP1 923/4885
US-20040106599-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 NAMPT 243/4885HSP90B1 1260/4885TRAP1 923/4885
US-20060058298-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 NAMPT 243/4885HSP90B1 1260/4885TRAP1 923/4885
US-20040142953-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 NAMPT 243/4885HSP90B1 1260/4885TRAP1 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.